We are live on ! Find out more
RVPHW

Reviva Pharmaceuticals Warrants
RVPHW

Delisted

RVPHW was delisted on the 12th of December, 2025.

Back to rankings

16 hedge funds and large institutions have $2.62M invested in Reviva Pharmaceuticals Warrants in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $2.53M → $2.62M (+$81K)

0% more funds holding

Funds holding: 16 → 16 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Walleye Trading
Walleye Trading
New York
-$643
2
GCL
Glazer Capital LLC
New York
-$192
3
OAM
Oxford Asset Management
United Kingdom
-$96
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$2.02M – – –
BCM
2
BlueCrest Capital Management
Jersey
$151K – – –
GCL
3
Glazer Capital LLC
New York
$72K -$192 -1,000 -0.3%
AA
4
AQR Arbitrage
Connecticut
$62K – – –
OAM
5
Oxford Asset Management
United Kingdom
$54K -$96 -500 -0.2%
GCIA
6
Gabelli & Co Investment Advisers
New York
$49K – – –
Walleye Trading
7
Walleye Trading
New York
$41K -$643 -3,360 -1%
6CM
8
683 Capital Management
New York
$40K – – –
GF
9
Gabelli Funds
New York
$30K – – –
PAM
10
Panagora Asset Management
Massachusetts
$21K – – –
HIM
11
HGC Investment Management
Ontario, Canada
$20K – – –
PC
12
Periscope Capital
Ontario, Canada
$18K – – –
BCM
13
Bluefin Capital Management
New York
$15K – – –
BI
14
Bulldog Investors
New Jersey
$10K – – –
PAMP
15
Polar Asset Management Partners
Ontario, Canada
$8K – – –
CAC
16
Cowen and Company
New York
$5K +$3.83K +20,000 New

RVPHW Hedge Fund Activity: Q3 2019 in Review

16 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q3 2019, worth a combined $2.62M — up 3.2% from $2.53M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new RVPHW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest seller was Walleye Trading, cutting an estimated $643.

  • 16 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $2.62M of Reviva Pharmaceuticals Warrants stock for Q3 2019, up 3.2% quarter-over-quarter.
  • 1 fund opened new Reviva Pharmaceuticals Warrants positions in Q3 2019 and 0 closed out, a net change of +1 holder.
  • The largest Reviva Pharmaceuticals Warrants seller in Q3 2019 was Walleye Trading, an estimated $643 sold.

Based on aggregated 13F filings for Q3 2019.